This study by Ito and colleagues provides in vivo evidence that miR-150 is capable of suppressing tumor metastasis and invasion by targeting the chemokine receptor or CCR6, which prevents autocrine signaling in advanced CTCL, particularly IL-22-CCL20-CCR6 signaling [123]. This evidence concerns the gene CCR6 and neoplasm.